European panel on low density lipoprotein (LDL) subclasses: A statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: Executive summary

Current Vascular Pharmacology

Volumn 9, Issue 5, 2011, Pages 531-532

  Mikhailidis, Dimitri P ^a   Elisaf, Moses ^b   Rizzo, Manfredi ^c   Berneis, Kaspar ^d   Griffin, Bruce ^e   Zambon, Alberto ^f   Athyros, Vasilios ^g   de Graaf, Jacqueline ^h   März, Winfried ⁱ   Parhofer, Klaus G ^j   Rini, Giovam Battista ^c   Spinas, Giatgen A ^d   Tomkin, Gerald H ^k   Tselepis, Alexandros D ^b   Wierzbicki, Anthony S ^l   Winkler, Karl ^m   Florentin, Matilda ^b   Liberopoulos, Evangelos ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF SURREY   (United Kingdom)

^f UNIVERSITY OF PADOVA   (Italy)

^g ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j UNIVERSITY OF MUNICH   (Germany)

^k TRINITY COLLEGE DUBLIN   (Ireland)

^l ST THOMAS HOSPITAL   (United Kingdom)

^m UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; SMALL DENSE LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; GEL ELECTROPHORESIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; ULTRACENTRIFUGATION;

ANIMALS; ATHEROSCLEROSIS; CLINICAL MEDICINE; ELECTROPHORESIS; HUMANS; LIFE STYLE; LIPOPROTEINS, LDL; MAGNETIC RESONANCE SPECTROSCOPY; MONITORING, PHYSIOLOGIC; ULTRACENTRIFUGATION;

EID: 80051769525     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016111796642698     Document Type: Article

References (1)

1. Mikhailidis DP, Elisaf M, Rizzo M, et al. European Panel on Low Density Lipoprotein (LDL) Subclasses: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol 2011; 9: 533-71.